Dividend Power Score
A single, comprehensive score designed to measure the true strength of a company’s dividend.
This score combines three essential pillars of dividend quality:
Consistency – Measures how reliable the dividend has been over time, focusing on payment history, stability, and the absence of cuts or suspensions.
Payability – Assesses the company’s financial ability to sustain its dividend, taking into account cash flow, earnings coverage, balance sheet strength, and overall financial health.
Growth – Evaluates the long-term growth of both the dividend and the company’s share price, highlighting businesses that consistently increase payouts while creating shareholder value.
Higher scores identify companies that have historically delivered dependable income alongside sustained dividend growth and long-term capital appreciation.
Company Overview
Kenvue Inc. is a global consumer health company focused on developing, manufacturing, and marketing everyday health, wellness, and personal care products. The company operates within the consumer health, personal care, and over-the-counter (OTC) pharmaceuticals industries, serving mass-market consumers, healthcare professionals, and retailers worldwide. Kenvue was formed through the separation of Johnson & Johnson’s consumer health business and became an independent, publicly traded company in 2023.
The company’s primary revenue drivers are its portfolio of well-established consumer brands spanning self-care, skin health and beauty, and essential health products. Kenvue’s strategic advantage lies in its ownership of long-standing, trusted brands with significant global market share, extensive retail distribution, and consumer loyalty. Its history traces back more than a century through Johnson & Johnson, with many core brands developed, acquired, and scaled globally before the formal corporate separation.
Business Operations
Kenvue generates revenue through three main operating segments: Self Care, Skin Health and Beauty, and Essential Health. Self Care includes OTC medicines such as pain relief, allergy, cough and cold, smoking cessation, and digestive health products. Skin Health and Beauty encompasses dermatological, facial care, and beauty brands sold through mass, specialty, and professional channels. Essential Health focuses on oral care, baby care, women’s health, and wound care products used in everyday hygiene and preventive health.
Operations span both domestic and international markets, with manufacturing, research, and distribution capabilities across multiple continents. Kenvue controls proprietary formulations, brand trademarks, and manufacturing processes while leveraging third-party suppliers for certain raw materials. The company maintains transitional and ongoing commercial relationships with Johnson & Johnson for select services and operates through numerous wholly owned subsidiaries that manage regional sales, regulatory compliance, and local manufacturing.
Strategic Position & Investments
Kenvue’s strategic direction centers on driving organic growth through brand investment, innovation in consumer-centric health solutions, and operational efficiency following its separation from Johnson & Johnson. Growth initiatives emphasize premiumization of skin health brands, expansion of self-care product lines, and increased digital and data-driven marketing capabilities. The company continues to invest in research and development to support product reformulations, line extensions, and regulatory approvals across key categories.
While Kenvue has not pursued large-scale transformational acquisitions since becoming independent, it actively evaluates bolt-on acquisitions and brand investments aligned with consumer health, dermatology, and wellness trends. The company’s portfolio includes globally recognized subsidiaries tied to individual brand families, and it remains engaged in emerging areas such as dermatologist-recommended skincare, science-backed wellness products, and consumer-driven health solutions.
Geographic Footprint
Kenvue operates globally, with corporate headquarters in North America and a significant presence across Europe, Asia-Pacific, Latin America, Middle East, and Africa. The company sells products in more than 165 countries, supported by a diversified manufacturing and supply chain network designed to serve local and regional markets efficiently.
Its international footprint reflects deep penetration in both developed and emerging markets, with established leadership positions in the United States, Western Europe, China, India, and key Latin American countries. Kenvue’s geographic diversification helps balance currency, regulatory, and demand risks while enabling the company to tailor product offerings to regional consumer preferences and healthcare systems.
Leadership & Governance
Kenvue is led by an experienced executive team with backgrounds in consumer health, pharmaceuticals, and global brand management. The leadership philosophy emphasizes brand trust, science-based innovation, disciplined capital allocation, and operational independence following the separation from Johnson & Johnson. Governance structures are designed to support long-term value creation, regulatory compliance, and strong oversight as a standalone public company.
Key executives include:
- Thibaut Mongon – Chief Executive Officer
- Paul Ruh – Chief Financial Officer
- Charmaine England – Chief Growth Officer
- Kirk Perry – President, Skin Health and Beauty
- Jon Snyder – Chief Legal & External Affairs Officer
- Vanessa Broadhurst – Chief Corporate Affairs Officer
The board of directors includes independent members with experience in global consumer products, healthcare, finance, and corporate governance, supporting strategic oversight and accountability.